Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00566943 · ClinicalTrials.gov registry record · NA

Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix

A NA study of Obesity, sponsored by Baxter Healthcare Corporation.

Completed
Registry status
NA
Development phase
101
Enrollment target
1
Study location

NCT00566943: Completed NA study of Obesity, sponsored by Baxter Healthcare Corporation.

NCT00566943 is a NA study of Obesity that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 101 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00566943, a NA study of Obesity, has completed, sponsored by Baxter Healthcare Corporation.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to verify the performance of PSD Veritas to provide staple line protection during surgical procedures for obesity.

Primary Outcome

Adverse events as measured through hospital discharge and 30 days post-discharge in both the linear and circular arms of the study.

Conditions Studied

Interventions

  • DEVICE PSD Veritas Collagen Matrix
  • PROCEDURE Roux-en-Y gastric by-pass surgery with no buttress

Study Locations (1)

Missouri

  • University of Missouri-Columbia - Columbia

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2006-03
Est. Completion 2008-12
Phase NA
Baxter Healthcare Corporation

46 total trials

What the finished NCT00566943 record still lists

NCT00566943 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which PSD Veritas Collagen Matrix is the first listed.

NCT00566943 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT00566943 about?

NCT00566943 is a clinical study titled "Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix". The purpose of this study is to verify the performance of PSD Veritas to provide staple line protection during surgical procedures for obesity.

What is the current status of trial NCT00566943?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2006-03. Estimated completion is 2008-12.

What conditions does trial NCT00566943 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT00566943?

The interventions under investigation include: PSD Veritas Collagen Matrix (DEVICE), Roux-en-Y gastric by-pass surgery with no buttress (PROCEDURE).

Who is sponsoring clinical trial NCT00566943?

This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00566943 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00566943's enrollment target sits among peer trials

101 473rd of 1053 higher than 577 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00566943, the US trial registry maintained by the National Library of Medicine. NCT00566943 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.